Enterocyte cholesterol metabolism (WP5333)

Homo sapiens

This pathway shows the cholesterol absorption and biosynthesis in the enterocyte.

Authors

Tom Pauly , Denise Slenter , Susan Coort , and Eric Weitz

Activity

last edited

Discuss this pathway

Check for ongoing discussions or start your own.

Cited In

Are you planning to include this pathway in your next publication? See How to Cite and add a link here to your paper once it's online.

Organisms

Homo sapiens

Communities

Annotations

Pathway Ontology

cholesterol metabolic pathway cholesterol transport pathway cholesterol biosynthetic pathway

Cell Type Ontology

enterocyte

Participants

Label Type Compact URI Comment
Esterase Metabolite hmdb:HMDB0302632
Phospholipase Metabolite hmdb:HMDB0302979
phospholipids Metabolite chebi:16247
cholesterol Metabolite chebi:16113
cholesterol esters Metabolite chebi:17002
triacylglycerols Metabolite chebi:17855
fatty acids Metabolite chebi:35366
diacylglycerols Metabolite chebi:18035
monoacylglycerols Metabolite chebi:17408
DGL Metabolite chebi:15966
lysophospholipids Metabolite chebi:16961
Acetyl-CoA Metabolite cas:72-89-9
HMG-CoA Metabolite hmdb:HMDB0001375
Mevalonic acid Metabolite cas:150-97-0
Mevalonic acid 5-pyrophosphate Metabolite cas:1492-08-6
Mevalonic acid-5P Metabolite cas:73566-35-5
isopentenyl pyrophosphate Metabolite cas:358-71-4
Dimethylallyl pyrophosphate Metabolite cas:358-72-5
Geranyl-PP Metabolite cas:6699-20-3
lanosterol Metabolite chebi:16521
(S)-2,3-Epoxysqualene Metabolite chebi:15441
farnesyl pyrophosphate Metabolite cas:13058-04-3
Squalene Metabolite cas:111-02-4
zymosterol Metabolite chebi:18252
desmosterol Metabolite chebi:17737
Zymostenol Metabolite chebi:16608
24,25-dihydrolanosterol Metabolite chebi:28113
Lathosterol Metabolite cas:80-99-9
7-Dehydrocholesterol Metabolite cas:434-16-2
Cholesterol Metabolite cas:57-88-5
SLC27A4 GeneProduct ensembl:ENSG00000167114
MTTP GeneProduct ensembl:ENSG00000138823
APOA1 GeneProduct ensembl:ENSG00000118137
DGAT1 GeneProduct ensembl:ENSG00000185000
APOA4 GeneProduct ensembl:ENSG00000110244
MGAT1 GeneProduct ensembl:ENSG00000131446
APOB GeneProduct ensembl:ENSG00000084674
ABCA1 GeneProduct ensembl:ENSG00000165029
ABCG8 GeneProduct ncbigene:64241
ABCG5 GeneProduct ncbigene:64240
NPC1L1 GeneProduct ensembl:ENSG00000015520
CD36 GeneProduct ensembl:ENSG00000135218
ACAT2 GeneProduct ensembl:ENSG00000120437
SAR1B GeneProduct ensembl:ENSG00000152700
HMGCS1 GeneProduct ncbigene:3157
HMGCR GeneProduct ncbigene:3156
MVD GeneProduct ncbigene:4597
PMVK GeneProduct ncbigene:10654
MVK GeneProduct ncbigene:4598
IDI1 GeneProduct ncbigene:3422
FDPS GeneProduct ncbigene:2224
SQLE GeneProduct ncbigene:6713
FDFT1 GeneProduct ncbigene:2222
LSS GeneProduct ncbigene:4047
DHCR24 GeneProduct ensembl:ENSG00000116133
EBP GeneProduct ensembl:ENSG00000147155
DHCR7 GeneProduct ncbigene:1717
SC5DL GeneProduct ncbigene:6309
CYP51A1 GeneProduct ensembl:ENSG00000001630
HSD17B7 GeneProduct ensembl:ENSG00000132196
NSDHL GeneProduct ncbigene:50814 NAD(P) dependent steroid dehydrogenase-like
SC4MOL GeneProduct ncbigene:6307
LBR GeneProduct ensembl:ENSG00000143815
TM7SF2 GeneProduct ensembl:ENSG00000149809
LDLR GeneProduct ensembl:ENSG00000130164
FABP2 GeneProduct ensembl:ENSG00000145384
Triacylglycerol lipase Protein uniprot:A0A087WX88

References

  1. Cholesterol esterase activity of human intestinal mucosa. Ponz de Leon M, Carubbi F, Di Donato P, Carulli N. Dig Dis Sci. 1985 Nov;30(11):1053–64. PubMed Europe PMC Scholia
  2. Phospholipases: structural and functional motifs for working at an interface. Roberts MF. FASEB J. 1996 Aug;10(10):1159–72. PubMed Europe PMC Scholia
  3. Mechanisms by Which LRP1 (Low-Density Lipoprotein Receptor-Related Protein-1) Maintains Arterial Integrity. Gonias SL. Arterioscler Thromb Vasc Biol. 2018 Nov;38(11):2548–9. PubMed Europe PMC Scholia
  4. The TICE Pathway: Mechanisms and Lipid-Lowering Therapies. Grefhorst A, Verkade HJ, Groen AK. Methodist Debakey Cardiovasc J. 2019;15(1):70–6. PubMed Europe PMC Scholia
  5. Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement. Hegele RA, Borén J, Ginsberg HN, Arca M, Averna M, Binder CJ, et al. Lancet Diabetes Endocrinol. 2020 Jan;8(1):50–67. PubMed Europe PMC Scholia
  6. Regulation of intestinal lipid metabolism: current concepts and relevance to disease. Ko CW, Qu J, Black DD, Tso P. Nat Rev Gastroenterol Hepatol. 2020 Mar;17(3):169–83. PubMed Europe PMC Scholia